Paramag Biosciences

Ultragenyx Pharmaceutical Inc, based in Novato, is at the forefront of rare disease medicine, dedicated to advancing the rare disease community. With a commitment to progress and innovation, Ultragenyx is shaping the future of healthcare for those with rare diseases. Driven by a mission to propel the rare disease field forward, Ultragenyx Pharmaceutical Inc is a leader in developing treatments and therapies for those in need. Their focus on rare diseases underscores their dedication to improving the lives of patients and caregivers worldwide. Generated from their website's infomation

EicOsis, based in Davis, CA, is pioneering innovative treatments for pain and inflammation by focusing on the soluble Epoxide Hydrolase (sEH) enzyme, which plays a key role in regulating the body's natural healing processes. Their approach aims to develop safe, non-addictive oral analgesics and anti-inflammatories, addressing the urgent need for better chronic pain medications amid the ongoing opioid crisis. The company is actively engaged in clinical trials to evaluate the safety and efficacy of its lead compound, currently undergoing Phase 1 human trials, while also contributing to scientific advancements in pain management and neuroprotection. EicOsis is led by Dr. Bruce Hammock, a distinguished figure in the field, whose contributions continue to shape the future of pain therapeutics. Generated from the website

Expanesthetics, Inc. is a company located in the University Research Park in Davis, California, dedicated to advancing the field of aesthetics through innovative scientific solutions. Their team focuses on impactful research and development to enhance experiences in the aesthetics industry. With a strong emphasis on collaboration and inquiry, Expanesthetics aims to drive advancements that benefit both professionals and clients alike. The organization encourages inquiries and engagement to further their mission in the realm of aesthetic sciences. Generated from the website